Medicines information publisher MIMS Australia will begin including international non-proprietary names (INNs) in addition to Australian approved names (AANs) in its drug reference systems from its data release next month.

The move is part of a four-year project led by the Therapeutic Goods Administration (TGA) under its International Harmonisation of Ingredient Names (IHIN) initiative, which will see terms like amoxycillin change over time to the standard international spelling amoxicillin.